(PDF) Pmu4 - The Safety of Switching Between Reference

Pmu4 - The Safety of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.1840

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Comment On: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

English

Adalimumab: A Review of the Reference Product and Biosimilars

English

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Gastroenterology

English

Nocebo in Biosimilars and Generics in Neurology: A Systematic Review

Frontiers in Pharmacology

English

Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence

English

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

English

A Systematic Review of the Efficacy and Safety of Fluoridation

Evidence-Based Dentistry

English

A Systematic Review of the Comparative Safety of Colloids

Archives of Surgery

English

The Role of Periodic Safety Update Reports in the Safety Management of Biopharmaceuticals

European Journal of Clinical Pharmacology

English